目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type
2.2.2. Type
2.2.3. End Use
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Prostate Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of prostate cancer
3.2.1.2. Increasing global geriatric population
3.2.1.3. Technological advancements in the field of cancer diagnostics
3.2.2. Market restraint analysis
3.2.2.1. High cost of diagnostics
3.3. Prostate Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Prostate Cancer Diagnostics Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Prostate Cancer Diagnostics Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Preliminary Tests
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. PSA Tests
4.4.1.2.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Free PSA Test
4.4.1.3.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Total PSA Test
4.4.1.4.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Other Preliminary Tests
4.4.1.5.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Confirmatory Tests
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Pca3 Test
4.4.2.2.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Trans-Rectal Ultrasound
4.4.2.3.1 Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Biopsy Test
4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Prostate Cancer Diagnostics Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Prostate Cancer Diagnostics Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Adenocarcinoma
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Interstitial Cell Carcinoma
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Other
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Prostate Cancer Diagnostics Market: End Use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Prostate Cancer Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Outpatient Facilities
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Home Care
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Research & Manufacturing
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Prostate Cancer Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. MDx Health
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Test Type benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Myriad Genetics, Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Test Type benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Abbott Laboratories
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Test Type benchmarking
8.3.6.4. Strategic initiatives
8.3.7. F. Hoffman-La Roche AG
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Test Type benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bayer AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Test Type benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Siemens Healthcare GmbH
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Test Type benchmarking
8.3.9.4. Strategic initiatives
8.3.10. OPKO Health, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Test Type benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Genomic Health.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Test Type benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Pfizer Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Test Type benchmarking
8.3.12.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America Prostate Cancer Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 4 North America Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 5 North America Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe Prostate Cancer Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 13 Europe Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 14 Europe Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 Europe Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 Germany Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 18 Germany Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 19 UK Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 20 UK Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 UK Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 France Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 23 France Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 24 France Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 Italy Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Spain Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 30 Spain Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 31 Denmark Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 32 Denmark Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 33 Denmark Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 34 Sweden Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 35 Sweden Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Sweden Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Norway Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 38 Norway Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 39 Norway Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Prostate Cancer Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 44 China Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 45 China Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 46 China Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 47 Japan Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 Japan Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 India Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 51 India Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 52 India Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 South Korea Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 54 South Korea Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 55 South Korea Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 56 Australia Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 57 Australia Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 Australia Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 Thailand Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 60 Thailand Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 Thailand Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 62 Latin America Prostate Cancer Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 64 Latin America Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 65 Latin America Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 Brazil Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 67 Brazil Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 68 Brazil Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 69 Mexico Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 70 Mexico Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 71 Mexico Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 72 Argentina Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 73 Argentina Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 74 Argentina Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 75 MEA Prostate Cancer Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 76 MEA Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 77 MEA Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 78 MEA Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 79 South Africa Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 80 South Africa Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 81 South Africa Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 85 UAE Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 86 UAE Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 87 UAE Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 88 Kuwait Prostate Cancer Diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 89 Kuwait Prostate Cancer Diagnostics market, by type, 2018 - 2030 (USD Million)
Table 90 Kuwait Prostate Cancer Diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Prostate Cancer Diagnostics market: market outlook
Fig. 14 Prostate Cancer Diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Prostate Cancer Diagnostics market driver impact
Fig. 20 Prostate Cancer Diagnostics market restraint impact
Fig. 21 Prostate Cancer Diagnostics market strategic initiatives analysis
Fig. 22 Prostate Cancer Diagnostics market: Test Type movement analysis
Fig. 23 Prostate Cancer Diagnostics market: Test Type outlook and key takeaways
Fig. 24 Preliminary Tests Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 25 PSA Tests Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 26 Free PSA Test Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 27 Total PSA Test Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 28 Other Preliminary Tests Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 29 Confirmatory Tests Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 30 Pca3 Test Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 31 Trans-Rectal Ultrasound Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 32 Biopsy Test Prostate Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 33 Prostate Cancer Diagnostics Market: Type movement Analysis
Fig. 34 Prostate Cancer Diagnostics market: Type outlook and key takeaways
Fig. 35 Adenocarcinoma market estimates and forecasts, 2018 - 2030
Fig. 36 Interstitial Cell Carcinoma market estimates and forecasts,2018 - 2030
Fig. 37 Other market estimates and forecasts,2018 - 2030
Fig. 38 Prostate Cancer Diagnostics market: End Use movement analysis
Fig. 39 Prostate Cancer Diagnostics market: End Use outlook and key takeaways
Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 41 Outpatient Facilities market estimates and forecasts,2018 - 2030
Fig. 42 Home Care market estimates and forecasts, 2018 - 2030
Fig. 43 Research & Manufacturing market estimates and forecasts,2018 - 2030
Fig. 44 Global Prostate Cancer Diagnostics market: Regional movement analysis
Fig. 45 Global Prostate Cancer Diagnostics market: Regional outlook and key takeaways
Fig. 46 Global Prostate Cancer Diagnostics market share and leading players
Fig. 47 North America market share and leading players
Fig. 48 Europe market share and leading players
Fig. 49 Asia Pacific market share and leading players
Fig. 50 Latin America market share and leading players
Fig. 51 Middle East & Africa market share and leading players
Fig. 52 North America: SWOT
Fig. 53 Europe SWOT
Fig. 54 Asia Pacific SWOT
Fig. 55 Latin America SWOT
Fig. 56 MEA SWOT
Fig. 57 North America, by country
Fig. 58 North America
Fig. 59 North America market estimates and forecasts, 2018 - 2030
Fig. 60 U.S.
Fig. 61 U.S. market estimates and forecasts, 2018 - 2030
Fig. 62 Canada
Fig. 63 Canada market estimates and forecasts, 2018 - 2030
Fig. 64 Europe
Fig. 65 Europe market estimates and forecasts, 2018 - 2030
Fig. 66 UK
Fig. 67 UK market estimates and forecasts, 2018 - 2030
Fig. 68 Germany
Fig. 69 Germany market estimates and forecasts, 2018 - 2030
Fig. 70 France
Fig. 71 France market estimates and forecasts, 2018 - 2030
Fig. 72 Italy
Fig. 73 Italy market estimates and forecasts, 2018 - 2030
Fig. 74 Spain
Fig. 75 Spain market estimates and forecasts, 2018 - 2030
Fig. 76 Denmark
Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
Fig. 78 Sweden
Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
Fig. 80 Norway
Fig. 81 Norway market estimates and forecasts, 2018 - 2030
Fig. 82 Asia Pacific
Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 84 China
Fig. 85 China market estimates and forecasts, 2018 - 2030
Fig. 86 Japan
Fig. 87 Japan market estimates and forecasts, 2018 - 2030
Fig. 88 India
Fig. 89 India market estimates and forecasts, 2018 - 2030
Fig. 90 Thailand
Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
Fig. 92 South Korea
Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
Fig. 94 Australia
Fig. 95 Australia market estimates and forecasts, 2018 - 2030
Fig. 96 Latin America
Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
Fig. 98 Brazil
Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
Fig. 100 Mexico
Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
Fig. 102 Argentina
Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
Fig. 104 Middle East and Africa
Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 106 South Africa
Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
Fig. 108 Saudi Arabia
Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 110 UAE
Fig. 111 UAE market estimates and forecasts, 2018 - 2030
Fig. 112 Kuwait
Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 114 Market share of key market players - Prostate Cancer Diagnostics market